Literature DB >> 27769956

Data-Driven Iterative Refinement of Bone Marrow Testing Protocols Leads to Progressive Improvement in Cytogenetic and Molecular Test Utilization.

Adam C Seegmiller, Annette S Kim, Claudio A Mosse, Aaron C Shaver, Mary Ann Thompson, Shaoying Li, David R Head, Mary M Zutter.   

Abstract

OBJECTIVES: To determine the effect of iterative refinement of standard ordering protocols on test utilization and results for bone marrow biopsy specimens.
METHODS: Eighteen months of test utilization and result data were used to revise the protocols that determine cytogenetic and molecular test selection on bone marrow specimens and then compared with data obtained following protocol revision.
RESULTS: Revision of protocols resulted in reduction in total tests and associated charges, due to a decrease in tests both concordant and discordant with the protocols. These reductions only occurred in diseases for which revisions were made and were limited to cases in which reflex testing was performed. There was an increase in the fraction of positive tests, which was also limited to reflex testing.
CONCLUSIONS: Data-driven iterative revision of protocols further improves test utilization and performance, while reducing cost. Analysis of testing data can be used to continuously improve test ordering decisions. © American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Bone marrow; Hematopathology; Test utilization

Mesh:

Year:  2016        PMID: 27769956     DOI: 10.1093/ajcp/aqw180

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-up.

Authors:  Ferrin C Wheeler; Annette S Kim; Claudio A Mosse; Aaron C Shaver; Ashwini Yenamandra; Adam C Seegmiller
Journal:  Am J Clin Pathol       Date:  2018-03-29       Impact factor: 2.493

2.  Improving Cancer Diagnosis and Care: Patient Access to High-Quality Oncologic Pathology.

Authors:  Sharyl J Nass; Michael B Cohen; Ritu Nayar; Mary M Zutter; Erin P Balogh; Richard L Schilsky; Hedvig Hricak; Kojo S J Elenitoba-Johnson
Journal:  Oncologist       Date:  2019-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.